Found 44 matching trials
COVID Protection After Transplant-Immunosuppression Reduction PHASE2 This study will enroll individuals who have:
* Completed primary series of...
Show More Location
University of California, San Diego
Learn More & Join Trial
Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD) PHASE2 The immune system has offensive and defensive capacities. In bone marrow tr...
Show More Location
Katholieke Universiteit Leuven
Learn More & Join Trial
A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms PHASE4 To determine if conversion to enteric coated MPA allows an escalated dose o...
Show More Learn More & Join Trial
Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation PHASE2 Viral infections can profoundly influence alloimmune responses and hamper a...
Show More Location
Hospital Clinic Barcelona, University of Barcelona
Learn More & Join Trial
Study of Everolimus in de Novo Renal Transplant Recipients NA In the present study, the investigators propose a conversion scheme with 50...
Show More Location
Hospital São João de Deus/Fundação Geraldo Corrêa
Learn More & Join Trial
Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant PHASE4 In spite of conventional immunosuppression with lymphocyte-depleting induct...
Show More Status
Active Not Recruiting
Location
Multiple Locations
Learn More & Join Trial
Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation NA The main objective of the study is to demonstrate the utility and safety of...
Show More Location
Institut klinické a experimentální mediciny
Learn More & Join Trial
Pilot Trial on Immunosuppression Modulation to Increase SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients PHASE1 Mycophenolate has been identified as risk factor for non-response to SARS-C...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial PHASE3 ASSIST I was the first randomized trial in patients with scleroderma to not...
Show More Location
Northwestern University
Learn More & Join Trial
Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal PHASE4 Current therapy to prevent organ rejection relies on the use of calcineurin...
Show More Location
Buffalo General Hospital Multi-Organ Transplant Department
Learn More & Join Trial